Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06145633
What this trial is testing

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Fred Hutchinson Cancer Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT07644598
What this trial is testing

MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Georgetown University 58
Not applicableUnknownNCT05584787
What this trial is testing

Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis

Who this might be right for
Prostate Cancer
San Carlo di Nancy Hospital 20
Not applicableStudy completedNCT01423474
What this trial is testing

Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time

Who this might be right for
Prostatic Neoplasms
CancerCare Manitoba 152
Testing effectiveness (Phase 2)Ended earlyNCT02459912
What this trial is testing

Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer

Who this might be right for
Prostate Cancer
NYU Langone Health 1
Testing effectiveness (Phase 2)Ended earlyNCT04066894
What this trial is testing

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

Who this might be right for
Low Anterior Resection SyndromeMalignant Anal NeoplasmMalignant Bladder Neoplasm+8 more
M.D. Anderson Cancer Center 3
Not applicableUnknownNCT04394676
What this trial is testing

The Impact of Low Pressure Pneumo in RARP II

Who this might be right for
Prostate Cancer
Metro Health, Michigan 600
Testing effectiveness (Phase 2)UnknownNCT02077335
What this trial is testing

Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
CSSS de Gatineau 50
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Not applicableWithdrawnNCT01673581
What this trial is testing

Shared Decision Making in Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Massachusetts General Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT07072728
What this trial is testing

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Who this might be right for
Adjustment DisorderAdjustment Disorder With Anxious MoodCancer+8 more
Psyence Australia Pty Ltd 87
Not applicableActive Not RecruitingNCT01617161
What this trial is testing

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Massachusetts General Hospital 454
Not applicableStudy completedNCT00977860
What this trial is testing

Hypofractionated SBRT For Prostate Cancer

Who this might be right for
Prostate Cancer
Adam Olson 163
Testing effectiveness (Phase 2)UnknownNCT01890096
What this trial is testing

A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

Who this might be right for
Carcinoma of the Prostate
Sunnybrook Health Sciences Centre 174
Not applicableActive Not RecruitingNCT01936883
What this trial is testing

Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 195
Early research (Phase 1)Study completedNCT02151760
What this trial is testing

Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 37
Not applicableStudy completedNCT00643994
What this trial is testing

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

Who this might be right for
Prostate CancerProstatic CancerProstate Neoplasms+2 more
Accuray Incorporated 379
Not applicableLooking for participantsNCT00949819
What this trial is testing

Active Surveillance for Cancer of the Prostate (ASCaP)

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 462
Testing effectiveness (Phase 2)UnknownNCT02165020
What this trial is testing

Hyaluronic Acid for Hypofractionated Prostate Radiotherapy

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 36
Testing effectiveness (Phase 2)Ended earlyNCT04264208
What this trial is testing

HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

Who this might be right for
Prostate Cancer
Andrei Iagaru 4
Next Page